Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × avelumab × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 8 Carcinoma, Transitional Cell 8 Carcinoma, Renal Cell 5 Carcinoma, Merkel Cell 5 Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Turcot syndrome 1 Thymoma 1 Sarcoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Osteosarcoma 1 Motor Activity 1 Microsatellite Instability 1 Metastatic Urothelial Cancer 1

Interventions

fludarabine 2 Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 Biopsy 2 treosulfan 1 talimogene laherparepvec 1 sodium-iodide symporter 1 sargramostim 1 romidepsin 1 relatlimab 1 pembrolizumab 1 entrectinib 1 cemiplimab 1 brincidofovir 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Polymerase Chain Reaction 1 Photons 1 Mycophenolic Acid 1 Lactones 1 Ipilimumab 1 Immunoglobulin G 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡